Premium
FibroBiologics Inc (FBLG)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
FibroBiologics, Inc., a clinical-stage biotechnology company, engages in the development and commercialization of fibroblast-based therapies for patients suffering from chronic diseases. The company’s product pipeline includes CYWC628 which has completed pre-clinical trial for the treatment of wound... FibroBiologics, Inc., a clinical-stage biotechnology company, engages in the development and commercialization of fibroblast-based therapies for patients suffering from chronic diseases. The company’s product pipeline includes CYWC628 which has completed pre-clinical trial for the treatment of wound healing; CYMS101 which has completed Phase 1 trial for the treatment of multiple sclerosis; CybroCell for the treatment of degenerative disc disease; and CYPS317 for the treatment of psoriasis. It also develops early-stage research products, including CYTER915 to treat the human longevity; and TCB190 for the treatment of certain cancers. FibroBiologics, Inc. was incorporated in 2021 and is headquartered in Houston, Texas. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.0796 | -8.65217391304 | 0.92 | 0.9782 | 0.836 | 67860 | 0.88007658 | CS |
| 4 | -0.0898 | -9.65383788433 | 0.9302 | 1.04 | 0.731 | 197764 | 0.8401056 | CS |
| 12 | -0.5596 | -39.9714285714 | 1.4 | 1.83 | 0.731 | 250400 | 1.12125901 | CS |
| 26 | 0.492 | 141.216991963 | 0.3484 | 3.965 | 0.185 | 733591 | 0.62059075 | CS |
| 52 | 0.2404 | 40.0666666667 | 0.6 | 3.965 | 0.185 | 996595 | 0.45809529 | CS |
| 156 | -29.1596 | -97.1986666667 | 30 | 55 | 0.185 | 558235 | 1.23473614 | CS |
| 260 | -29.1596 | -97.1986666667 | 30 | 55 | 0.185 | 558235 | 1.23473614 | CS |
Transactions différées
Pour obtenir des transactions en temps réel, améliorez votre compte
Passer à la version en temps réel| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
